{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:53:03Z","timestamp":1793746383414,"version":"4.6.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019751","name":"JSS Academy of Higher Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ayurveda and Integrative Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jaim.2026.101343","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T10:47:49Z","timestamp":1779792469000},"page":"101343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Navigating the regulatory landscape of herbal medicines: A global comparison of India, China, Europe, the United States and Japan"],"prefix":"10.1016","volume":"17","author":[{"given":"Anil Tukaram","family":"Pawar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.B.","family":"Chandrasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6804-1023","authenticated-orcid":false,"given":"M.P.","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaim.2026.101343_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fphar.2013.00177","article-title":"The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety","volume":"4","author":"Ekor","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaim.2026.101343_bib2","series-title":"Herbal medicine phytochemistry. Reference series in phytochemistry","first-page":"1","article-title":"Adoption and application of biotechnology in herbal medicine practices","author":"Ogidi","year":"2023"},{"key":"10.1016\/j.jaim.2026.101343_bib3","unstructured":"Global Herbal Medicine Market [Online]. BCC Research. Available: <https:\/\/www.bccresearch.com\/market-research\/pharmaceuticals\/herbal-medicine-market.html> Accessed September 19, 2024."},{"issue":"8","key":"10.1016\/j.jaim.2026.101343_bib4","first-page":"904","article-title":"Two cases of pneumonia caused by sSho-saiko-to","volume":"34","author":"Tojima","year":"1996","journal-title":"Jpn J Thorac Dis"},{"issue":"1","key":"10.1016\/j.jaim.2026.101343_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3164\/jcbn.2007001","article-title":"Current status of herbal drugs in India: an overview","volume":"41","author":"Vaidya","year":"2007","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.jaim.2026.101343_bib6","series-title":"Pharmaceutical calibration, validation and qualification: a comprehensive approach","first-page":"199","article-title":"Regulatory requirements for herbal medicines in India","year":"2023"},{"key":"10.1016\/j.jaim.2026.101343_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112617","article-title":"The transnational Sowa Rigpa industry in Asia: new perspectives on an emerging economy","volume":"245","author":"Kloos","year":"2020","journal-title":"Soc Sci Med"},{"issue":"3","key":"10.1016\/j.jaim.2026.101343_bib8","first-page":"30","article-title":"Regulatory status of herbal drugs in India","volume":"7","author":"Devi","year":"2022","journal-title":"Int J Appl Pharm Sci Res"},{"key":"10.1016\/j.jaim.2026.101343_bib9","series-title":"Good clinical practice guidelines for clinical trials in ayurveda, siddha and unani medicines (GCP-ASU)","year":"2013"},{"issue":"7","key":"10.1016\/j.jaim.2026.101343_bib10","first-page":"415","article-title":"Clinical trials of traditional herbal medicines in India: current status and challenges","volume":"1","author":"Singh","year":"2014","journal-title":"Int J Pharmacogn"},{"key":"10.1016\/j.jaim.2026.101343_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104647","article-title":"Regulatory landscape of dietary supplements and herbal medicines from a global perspective","volume":"114","author":"Thakkar","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"issue":"3","key":"10.1016\/j.jaim.2026.101343_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.31254\/jahm.2015.1301","article-title":"Herbal Pharmacopoeias-An overview of international and Indian representation","volume":"1","author":"Sunil Kumar","year":"2015","journal-title":"J Ayu Herb Med"},{"issue":"2","key":"10.1016\/j.jaim.2026.101343_bib13","first-page":"210","article-title":"Plant active metabolites: a new paradigm in the treatment of hypertension (A brief description of Indian Pharmacopoeia-2022 herbal monographs)","volume":"14","author":"Tiwari","year":"2023","journal-title":"Indian Journal of Natural Products and Resources"},{"issue":"3","key":"10.1016\/j.jaim.2026.101343_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaim.2016.08.005","article-title":"Ayurvedic drugs in case: claims, evidence, regulations and ethics","volume":"7","author":"Patwardhan","year":"2016","journal-title":"J Ayurveda Integr Med"},{"key":"10.1016\/j.jaim.2026.101343_bib15","unstructured":"Guidelines to restrict Ayush products of medicinal use [Online]. PIB Delhi. Available: <https:\/\/www.pib.gov.in\/PressReleasePage.aspx?PRID=1808149&reg=3&lang=2> Accessed January 28, 2026."},{"key":"10.1016\/j.jaim.2026.101343_bib16","unstructured":"High microbial contamination in herbal drugs, says ICMR-NIN study [Online]. The Times of India. Available:<https:\/\/timesofindia.indiatimes.com\/city\/hyderabad\/high-microbial-contamination-in-herbal-drugs-says-icmr-nin-study\/articleshow\/123265883.cms> Accessed January 28, 2026."},{"key":"10.1016\/j.jaim.2026.101343_bib17","series-title":"Evidence-based validation of herbal medicine","first-page":"1","article-title":"Evidence-based validation of herbal medicine: translational approach","author":"Mukherjee","year":"2022"},{"issue":"2","key":"10.1016\/j.jaim.2026.101343_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/2229-3485.179435","article-title":"Phytopharmaceuticals: a new drug class regulated in India","volume":"7","author":"Bhatt","year":"2016","journal-title":"Perspect Clin Res"},{"issue":"5","key":"10.1016\/j.jaim.2026.101343_bib19","first-page":"54","article-title":"Herbal medicine regulation in China, Germany, and the United States","volume":"9","author":"Liu","year":"2010","journal-title":"Integr Med"},{"key":"10.1016\/j.jaim.2026.101343_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jep.2016.11.047","article-title":"How do government regulations influence the ability to practice Chinese herbal medicine in Western countries","volume":"196","author":"Fleischer","year":"2017","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"10.1016\/j.jaim.2026.101343_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jep.2012.02.029","article-title":"Future development of global regulations of Chinese herbal products","volume":"140","author":"Fan","year":"2012","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.jaim.2026.101343_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ki.2008.129","article-title":"Aristolochic acid nephropathy: a worldwide problem","volume":"74","author":"Debelle","year":"2008","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jaim.2026.101343_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.eng.2018.11.012","article-title":"The globalization of traditional medicines: perspectives related to the European Union regulatory environment","volume":"5","author":"Knoess","year":"2019","journal-title":"Engineering"},{"key":"10.1016\/j.jaim.2026.101343_bib24","unstructured":"Herbal Medicinal Products [Online]. European Medicines Agency. Available: <http:\/\/www.ema.europa.eu\/en\/human-regulatory\/herbal-medicinal-products>AccessedNovember9, 2023."},{"key":"10.1016\/j.jaim.2026.101343_bib25","unstructured":"Committee on Herbal Medicinal Products [Online]. European Medicines Agency. Available: < http:\/\/www.ema.europa.eu\/en\/committees\/committee-herbal-medicinal-products-hmpc>AccessedNovember8, 2023."},{"key":"10.1016\/j.jaim.2026.101343_bib26","unstructured":"European Union Monographs and List Entries [Online]. European Medicines Agency. Available: <http:\/\/www.ema.europa.eu\/en\/human-regulatory\/herbal-products\/european-union-monographs-list-entries>AccessedNovember9, 2023."},{"issue":"Pt B","key":"10.1016\/j.jaim.2026.101343_bib27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jep.2014.07.015","article-title":"The use of community herbal monographs to facilitate registrations and authorisations of herbal medicinal products in the European Union 2004-2012","volume":"158","author":"Peschel","year":"2014","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10.1016\/j.jaim.2026.101343_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4103\/0975-7406.168030","article-title":"Current status of herbal product: regulatory overview","volume":"7","author":"Sharma","year":"2015","journal-title":"J Pharm BioAllied Sci"},{"key":"10.1016\/j.jaim.2026.101343_bib30","series-title":"Dietary supplements: a framework for evaluating safety","year":"2005"},{"issue":"6","key":"10.1016\/j.jaim.2026.101343_bib31","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s11606-008-0632-y","article-title":"Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at university of California, San Francisco medical center","volume":"23","author":"Bent","year":"2008","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.jaim.2026.101343_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.14227\/DT240217P6","article-title":"Dissolution testing of herbal medicines: challenges and regulatory standards in Europe, the United States, Canada, and Asia","volume":"24","author":"Disch","year":"2017","journal-title":"Dissolution Technol"},{"key":"10.1016\/j.jaim.2026.101343_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5833945","article-title":"Advancing the regulation of traditional and complementary medicine products: a comparison of five regulatory systems on traditional medicines with a long history of use","volume":"2021","author":"Liang","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.jaim.2026.101343_bib34","unstructured":"Herbal Medicines Compendium [Online]. U. S. Pharmacopeia. Available: <https:\/\/hmc.usp.org\/about\/about-the-herbal-medicines-compendium>Accessed November 10, 2023."},{"issue":"7","key":"10.1016\/j.jaim.2026.101343_bib35","article-title":"Clinical implications of herbal supplements in conventional medical practice: a US perspective","volume":"14","author":"Hassen","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.jaim.2026.101343_bib36","first-page":"136","article-title":"Banned, but not forgotten: a case of ephedrine-induced psychosis","volume":"6","author":"Kim","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.jaim.2026.101343_bib37","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/phar.2280","article-title":"Kratom use and toxicities in the United States","volume":"39","author":"Eggleston","year":"2019","journal-title":"Pharmacotherapy"},{"issue":"Pt B","key":"10.1016\/j.jaim.2026.101343_bib38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jep.2014.07.012","article-title":"Regulation of traditional herbal medicinal products in Japan","volume":"158","author":"Maegawa","year":"2014","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"10.1016\/j.jaim.2026.101343_bib39","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/17512433.2016.1195263","article-title":"Herbal medicines: challenges in the modern world. Part 3. China and Japan","volume":"9","author":"Teng","year":"2016","journal-title":"Expet Rev Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.jaim.2026.101343_bib40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0192-0561(00)00007-2","article-title":"Modulation of lung local immune responses by oral administration of a herbal medicine sho-saiko-to","volume":"22","author":"Ohtake","year":"2000","journal-title":"Int J Immunopharm"},{"issue":"1","key":"10.1016\/j.jaim.2026.101343_bib41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12906-024-04428-y","article-title":"Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese adverse drug event report database","volume":"24","author":"Oura","year":"2024","journal-title":"BMC Complement Med Ther"},{"issue":"Part B","key":"10.1016\/j.jaim.2026.101343_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jep.2014.06.037","article-title":"Regulation of natural health products in Canada","volume":"158","author":"Smith","year":"2014","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.jaim.2026.101343_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/ecam\/nel034","article-title":"The state of the art of traditional Arab herbal medicine in the eastern region of the mediterranean: a review","volume":"3","author":"Azaizeh","year":"2006","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.jaim.2026.101343_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0300-483X(02)00483-3","article-title":"The regulation of herbal medicines in Australia","volume":"181\u2013182","author":"Briggs","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.jaim.2026.101343_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.11604\/pamj-oh.2024.15.8.45309","article-title":"Regulation and practice of clinical trials of herbal medicines in French-speaking West African countries (WAEMU): current status and challenges","volume":"15","author":"Sangho","year":"2024","journal-title":"PAMJ One Health"},{"key":"10.1016\/j.jaim.2026.101343_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1392330","article-title":"Traditional herbal medicine regulatory implementation in Ethiopia: a qualitative study","volume":"15","author":"Usure","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaim.2026.101343_bib48","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.15.04265","article-title":"Steps taken by the world health organization African region member states to standardise herbal medicines: a literature review","volume":"15","author":"Kithinji","year":"2025","journal-title":"J Glob Health"},{"key":"10.1016\/j.jaim.2026.101343_bib49","series-title":"Advances in phytomedicine","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1572-557X(02)80030-7","article-title":"Regulation of herbal medicines in Nigeria: the role of the National Agency for Food and Drug Administration and Control (NAFDAC)","author":"Osuide","year":"2002"},{"issue":"1","key":"10.1016\/j.jaim.2026.101343_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12906-025-04812-2","article-title":"Traditional medicine regulation status and challenges in Malawi and Nigeria","volume":"25","author":"Mponda","year":"2025","journal-title":"BMC Complement Med Ther"},{"issue":"10","key":"10.1016\/j.jaim.2026.101343_bib51","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.5958\/0974-360X.2015.00260.7","article-title":"Certificate of pharmaceutical product CoPP","volume":"8","author":"Meena","year":"2015","journal-title":"Res J Pharm Technol"},{"issue":"4","key":"10.1016\/j.jaim.2026.101343_bib52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0974-7788.76779","article-title":"The national pharmacovigilance program for Ayurveda, Siddha and Unani drugs: current status","volume":"1","author":"Baghel","year":"2010","journal-title":"Int J Ayurveda Res"},{"issue":"25","key":"10.1016\/j.jaim.2026.101343_bib53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/0973-1296.75905","article-title":"Pharmacovigilance of herbal medicines: current state and future directions","volume":"7","author":"Shetti","year":"2011","journal-title":"Pharmacogn Mag"},{"issue":"3","key":"10.1016\/j.jaim.2026.101343_bib54","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4103\/0975-1483.83780","article-title":"Pharmacovigilance of herbal products in India","volume":"3","author":"Wal","year":"2011","journal-title":"J Young Pharm"},{"issue":"10","key":"10.1016\/j.jaim.2026.101343_bib55","doi-asserted-by":"crossref","first-page":"13499","DOI":"10.1007\/s00210-025-04066-2","article-title":"Advancing herbal medicine safety: the need for a global pharmacovigilance approach","volume":"398","author":"Sethi","year":"2025","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"10.1016\/j.jaim.2026.101343_bib56","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/bcp.15277","article-title":"Pharmacovigilance in China: evolution and future challenges","volume":"89","author":"Song","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaim.2026.101343_bib57","series-title":"Pharmacovigilance for herbal and traditional medicines","first-page":"371","article-title":"Pharmacovigilance for herbal and traditional medicines in Japan","author":"Teng","year":"2022"},{"issue":"3","key":"10.1016\/j.jaim.2026.101343_bib58","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jep.2012.01.051","article-title":"Pharmacovigilance of herbal medicine","volume":"140","author":"Shaw","year":"2012","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jaim.2026.101343_bib59","article-title":"Advancing herbal medicine: enhancing product quality and safety through robust quality control practices","volume":"14","author":"Wang","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaim.2026.101343_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.talo.2021.100070","article-title":"Quality control of herbal drugs and preparations: the methods of analysis, their relevance and applications","volume":"4","author":"Muyumba","year":"2021","journal-title":"Talanta Open"},{"issue":"6","key":"10.1016\/j.jaim.2026.101343_bib61","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1248\/yakushi.19-00253-6","article-title":"Standardization of crude drugs for the Japanese pharmacopoeia","volume":"140","author":"Hakamatsuka","year":"2020","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jaim.2026.101343_bib62","unstructured":"Traditional Knowledge Digital Library Unit (TKDL) [Online]. Council of Scientific & Industrial Research. Available: <https:\/\/www.csir.res.in\/en\/documents\/tkdl>Accessed October 20, 2025."},{"key":"10.1016\/j.jaim.2026.101343_bib63","unstructured":"Protecting India\u2019s Traditional Knowledge [Online]. WIPO Magazine. Available: <https:\/\/www.wipo.int\/en\/web\/wipo-magazine\/articles\/protecting-indias-traditional-knowledge-37721>Accessed October 22, 2025."},{"issue":"3","key":"10.1016\/j.jaim.2026.101343_bib64","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/medlaw\/fwad006","article-title":"Intellectual property protection for traditional medical knowledge in China's context: a round peg in a square hole?","volume":"31","author":"Xia","year":"2023","journal-title":"Med Law Rev"},{"key":"10.1016\/j.jaim.2026.101343_bib65","unstructured":"Intellectual Property and the Protection of Traditional Knowledge, Genetic resources and folklore: the Peruvian experience. Rosa Giannina Alvarez Nunez. [Online] Available: <https:\/\/www.mpil.de\/files\/pdf3\/mpunyb_14_thesis_rosa_12.pdf> Accessed October 20, 2025."},{"key":"10.1016\/j.jaim.2026.101343_bib66","unstructured":"Intellectual Propoerty and Traditional Medical Knowledge [Online]. WIFO. Available: <https:\/\/www.wipo.int\/edocs\/pubdocs\/en\/wipo-pub-rn2023-5-6-en-intellectual-property-and-traditional-medical-knowledge.pdf> Accessed October 21, 2025."},{"key":"10.1016\/j.jaim.2026.101343_bib67","article-title":"Integrating artificial intelligence into the modernization of traditional Chinese medicine industry: a review","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.jaim.2026.101343_bib68","first-page":"973","article-title":"Advancements and challenges in the integration of artificial intelligence with herbal medicine research","volume":"2","author":"Patil","year":"2024","journal-title":"Int J Pharm Sci"},{"issue":"4","key":"10.1016\/j.jaim.2026.101343_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaim.2024.101028","article-title":"Danish ban on Ashwagandha: Truth, evidence, ethics, and regulations","volume":"15","author":"Patwardhan","year":"2024","journal-title":"J Ayurveda Integr Med"},{"issue":"7370","key":"10.1016\/j.jaim.2026.101343_bib70","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.325.7370.924\/e","article-title":"FDA urged to ban ephedrine from dietary supplements","volume":"325","author":"Charatan","year":"2002","journal-title":"Br Med J"},{"key":"10.1016\/j.jaim.2026.101343_bib71","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jep.2016.06.052","article-title":"Botanical drugs in Ayurveda and traditional Chinese medicine","volume":"194","author":"Jaiswal","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jaim.2026.101343_bib72","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jep.2016.07.064","article-title":"Contributions of Indian Council of Medical Research (ICMR) in the area of medicinal plants\/traditional medicine","volume":"197","author":"Tandon","year":"2017","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.jaim.2026.101343_bib73","doi-asserted-by":"crossref","first-page":"30","DOI":"10.22270\/ijdra.v9i2.466","article-title":"Current regulations for herbal medicines in India","volume":"9","author":"Singh","year":"2021","journal-title":"Int J Drug Regul Affairs"},{"issue":"3","key":"10.1016\/j.jaim.2026.101343_bib74","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1081\/CRP-120023840","article-title":"Exploring botanicals in Indian system of medicine-regulatory perspectives","volume":"20","author":"Mukherjee","year":"2003","journal-title":"Clin Res Regul Aff"},{"issue":"1","key":"10.1016\/j.jaim.2026.101343_bib75","doi-asserted-by":"crossref","first-page":"78","DOI":"10.22270\/ijdra.v9i1.458","article-title":"A comprehensive study on regulation of herbal drugs in India, US and European Union","volume":"9","author":"Chegu","year":"2021","journal-title":"Int J Drug Regul Affairs"},{"key":"10.1016\/j.jaim.2026.101343_bib76","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.phymed.2018.03.048","article-title":"European regulation model for herbal medicine: the assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in member states","volume":"42","author":"Qu","year":"2018","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.jaim.2026.101343_bib77","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/bdrb.10053","article-title":"Regulatory issues concerning the safety, efficacy and quality of herbal remedies","volume":"68","author":"Rousseaux","year":"2003","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"12","key":"10.1016\/j.jaim.2026.101343_bib78","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/ptr.5933","article-title":"Current status of herbal drug standards in the Indian pharmacopoeia","volume":"31","author":"Prakash","year":"2017","journal-title":"Phytother Res"},{"issue":"8","key":"10.1016\/j.jaim.2026.101343_bib79","doi-asserted-by":"crossref","first-page":"690","DOI":"10.20959\/wjpr20178-9091","article-title":"Herbal medicines: overview on regulations in India and South Africa","volume":"6","author":"Kumar","year":"2017","journal-title":"World J Pharmaceut Res"},{"issue":"1","key":"10.1016\/j.jaim.2026.101343_bib80","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s12906-024-04697-7","article-title":"Study design of herbal medicine clinical trials: a descriptive analysis of published studies investigating the effects of herbal medicinal products on human participants","volume":"24","author":"Koonrungsesomboon","year":"2024","journal-title":"BMC Complement Med Ther"},{"issue":"4","key":"10.1016\/j.jaim.2026.101343_bib81","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4103\/0975-7406.168035","article-title":"Challenges and guidelines for clinical trial of herbal drugs","volume":"7","author":"Parveen","year":"2015","journal-title":"J Pharm BioAllied Sci"},{"key":"10.1016\/j.jaim.2026.101343_bib82","first-page":"15","article-title":"The legal and regulatory framework of herbal medicinal products in the European Union: a focus on the traditional herbal medicines category","volume":"45","author":"Anquez-Traxler","year":"2011","journal-title":"Ther Innov Regul Sci"}],"container-title":["Journal of Ayurveda and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0975947626000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0975947626000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:29:02Z","timestamp":1786516142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0975947626000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0975947626000276"],"URL":"https:\/\/doi.org\/10.1016\/j.jaim.2026.101343","relation":{},"ISSN":["0975-9476"],"issn-type":[{"value":"0975-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the regulatory landscape of herbal medicines: A global comparison of India, China, Europe, the United States and Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Ayurveda and Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaim.2026.101343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Institute of Transdisciplinary Health Science and Technology and World Ayurveda Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101343"}}